2-pyrrolino-dox has been researched along with paraoxon in 1 studies
| Studies (2-pyrrolino-dox) | Trials (2-pyrrolino-dox) | Recent Studies (post-2010) (2-pyrrolino-dox) | Studies (paraoxon) | Trials (paraoxon) | Recent Studies (post-2010) (paraoxon) |
|---|---|---|---|---|---|
| 28 | 0 | 2 | 1,516 | 3 | 354 |
| Protein | Taxonomy | 2-pyrrolino-dox (IC50) | paraoxon (IC50) |
|---|---|---|---|
| Fatty-acid amide hydrolase 1 | Mus musculus (house mouse) | 5.9 | |
| Carbonic anhydrase 1 | Homo sapiens (human) | 0.338 | |
| Carbonic anhydrase 2 | Homo sapiens (human) | 0.059 | |
| Cholinesterase | Homo sapiens (human) | 0.007 | |
| Acetylcholinesterase | Mus musculus (house mouse) | 0.013 | |
| Acetylcholinesterase | Homo sapiens (human) | 0.01 | |
| Carbonic anhydrase 13 | Mus musculus (house mouse) | 1.021 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nagy, A; Plonowski, A; Schally, AV | 1 |
1 other study(ies) available for 2-pyrrolino-dox and paraoxon
| Article | Year |
|---|---|
Stability of cytotoxic luteinizing hormone-releasing hormone conjugate (AN-152) containing doxorubicin 14-O-hemiglutarate in mouse and human serum in vitro: implications for the design of preclinical studies.
Topics: Adult; Animals; Antineoplastic Agents; Bombesin; Carboxylesterase; Carboxylic Ester Hydrolases; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Doxorubicin; Drug Evaluation, Preclinical; Drug Interactions; Drug Stability; Gonadotropin-Releasing Hormone; Half-Life; Humans; Hydrolysis; Isoflurophate; Male; Mice; Mice, Nude; Nitrophenols; Paraoxon; Pyrroles; Weight Loss | 2000 |